Key result
Sumatriptan induces severe coronary artery spasm secondary to recent SARS-CoV-2 booster-triggered myocarditis and Graves' disease.
Case Report (n=1)
This case highlights the potential for severe coronary artery spasm induced by a 5HT1-agonist in the setting of newly diagnosed Graves' disease and myocarditis, possibly triggered by a SARS-CoV-2 booster vaccine.
Answers are grounded in this paper and cite their sources.
May warrant caution with sumatriptan in myocarditis or Graves' disease; leaves open vaccine-related spasm triggers.
BACKGROUND: Coronary artery spasm is a well-known potential side effect of selective 5-hydroxytryptamine type 1 (5HT1) receptor agonists and, therefore, contraindicated in patients with cardiovascular disease. SARS-CoV-2 vaccination has been associated with myocarditis, mainly in young men. CASE SUMMARY: A 55-year-old man with longstanding cluster headache, treated with the 5HT1-agonist Sumatriptan for ten years, received the mRNA-1273 SARS-CoV-2 booster vaccine. Four days later, he developed severe retrosternal pain several minutes after administering Sumatriptan with electrographic ST-elevation and a raised high-sensitivity cardiac troponin-T (hs-cTnT). Coronary angiogram was normal, but a diagnosis of acute myocarditis and hyperthyroidism secondary to Graves' disease was made. DISCUSSION: We present a case of severe coronary artery spasm induced by a 5HT1-agonist secondary to newly diagnosed Graves' disease and myocarditis. The mRNA-1273 SARS-CoV-2 booster vaccine administered four days before admission probably triggered both immunoreactions.
No takes yet. Share an insight, caveat, or question.
Vandebosch et al. (2023) conducted a case report in Coronary artery spasm, acute myocarditis, Graves' disease (n=1). Sumatriptan and mRNA-1273 SARS-CoV-2 booster vaccine was evaluated on Severe coronary artery spasm, acute myocarditis, and hyperthyroidism secondary to Graves' disease. A 55-year-old man developed severe coronary artery spasm induced by Sumatriptan, secondary to newly diagnosed Graves' disease and myocarditis, likely triggered by a recent SARS-CoV-2 booster vaccine.
Synapse has enriched 10 related papers. Consider them for comparative context: